Volume 46, Issue 6 , Pages 701-710, June 2007
Sex Differences in the Response of Children With ADHD to Once-Daily Formulations of Methylphenidate
To access this article, please choose from the options below
This study was funded by Celltech Pharmaceuticals, Inc., now UCB Pharma.Disclosure: Dr. Sonuga-Barke and Mr. Coghill are consultants to or have received support from Celltech/UCB, Janssen Cilag, Shire, and Eli Lilly. Mr. Coghill has also received support from Cephalon. Dr. Swanson is a consultant to Celltech/UCB, McNeil, and Eli Lilly and has also received research support from and acted as a consultant to Cephalon, Shire, and Novartis. Mr. Hatch is a consultant to UCB. Dr. Vandenberghe is an employee of UCB. Dr. Markowitz has received support from Novartis Pharmaceuticals and Eli Lilly.
PII: S0890-8567(09)62149-3
doi:10.1097/chi.0b013e31804659f1
© 2007 The American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Volume 46, Issue 6 , Pages 701-710, June 2007
